By contrast, the high-expressed mRNA level of TLE3 was connected with poor PFS (progress-free survival) of ovarian cancer, poor OS, FP, and PPS of gastric cancer, and poor RFS, PFS, and DSS of liver cancer. This evidence concerns the gene TLE3 and ovarian carcinoma.